Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review

被引:5
作者
Matteo, Serenelli [1 ]
Anna, Cantone [1 ]
Federico, Sanguettoli [1 ]
Daniele, Maio [1 ]
Gioele, Fabbri [1 ]
Beatrice, Dal Passo [1 ]
Rita, Pavasini [1 ]
Elisabetta, Tonet [1 ]
Giulia, Passarini [1 ]
Claudio, Rapezzi [1 ]
Gianluca, Campo [1 ]
机构
[1] Azienda Ospedaliero Universitaria Ferrara, Cardiovasc Inst, Ferrara, Italy
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 10卷
关键词
heart failure; amyloidosis; transthyretin; prognosis; stroke volume (SV); myocardial contraction fraction (MCF); CARDIAC AMYLOIDOSIS; AORTIC-STENOSIS; STAGING SYSTEM; WILD-TYPE; ECHOCARDIOGRAPHY; PREDICTORS; SURVIVAL;
D O I
10.3389/fcvm.2023.1085824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier phases and does not represent well the pathophysiology of CA. Many echocardiographic parameters resulted important diagnostic and prognostic tools in patients with CA. Stroke volume (SV) and myocardial contraction fraction (MCF) may be obtained both with echocardiography and cardiac magnetic resonance (MRI). They reflect many factors intrinsically related to the pathophysiology of CA and are therefore potentially associated with symptoms and prognosis in CA.Objectives: To collect and summarize the current evidence on SV and MCF and their clinical and prognostic role in transthyretin (TTR-CA).Methods and results: We performed a systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature database for studies focusing on SV and MCF in patients with TTR-CA. We analysed the following databases: PUBMED, Cochrane Library, EMBASE, and Web of Science database. Fourteen studies were included in the review. Both SV and MCF have important prognostic implications and are related to mortality. Furthermore, SV is more related to symptoms than LVEF and predicts tolerability of beta-blocker therapy in TTR-CA. Finally, SV showed to be an excellent measure to suggest the presence of TTR-CA in patients with severe aortic stenosis.Conclusion: Stroke volume and MCF are very informative parameters that should be routinely assessed during the standard echocardiographic examination of all patients with TTR-CA. They carry a prognostic role while being associated with patients' symptoms
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis
    Aimo, Alberto
    Vergaro, Giuseppe
    Castiglione, Vincenzo
    Rapezzi, Claudio
    Emdin, Michele
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 80 : 66 - 72
  • [2] Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy
    Arenja, Nisha
    Fritz, Thomas
    Andre, Florian
    Riffel, Johannes H.
    Siepen, Fabian Aus Dem
    Ochs, Marco
    Paffhausen, Judith
    Hegenbart, Ute
    Schoenland, Stefan
    Mueller-Hennessen, Matthias
    Giannitsis, Evangelos
    Kristen, Arnt V.
    Katus, Hugo A.
    Friedrich, Matthias G.
    Buss, Sebastian J.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2017, 18 (12) : 1414 - 1422
  • [3] Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
    Baumgartner, Helmut
    Hung, Judy
    Bermejo, Javier
    Chambers, John B.
    Evangelista, Arturo
    Griffin, Brian P.
    Iung, Bernard
    Otto, Catherine M.
    Pellikka, Patricia A.
    Quinones, Miguel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (01) : 1 - 23
  • [4] Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin Transthyretin Cardiac Amyloid Study (TRACS)
    Bhuiyan, Taslima
    Helmke, Stephen
    Patel, Ayan R.
    Ruberg, Frederick L.
    Packman, Jeff
    Cheung, Kin
    Grogan, Donna
    Maurer, Mathew S.
    [J]. CIRCULATION-HEART FAILURE, 2011, 4 (02) : 121 - 128
  • [5] Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis
    Boldrini, Michele
    Cappelli, Francesco
    Chacko, Liza
    Alejandra Restrepo-Cordoba, Maria
    Lopez-Sainz, Angela
    Giannoni, Alberto
    Aimo, Alberto
    Baggiano, Andrea
    Martinez-Naharro, Ana
    Whelan, Carol
    Quarta, Cristina
    Passino, Claudio
    Castiglione, Vincenzo
    Chubuchnyi, Vladyslav
    Spini, Valentina
    Taddei, Claudia
    Vergaro, Giuseppe
    Petrie, Aviva
    Ruiz-Guerrero, Luis
    Monivas, Vanessa
    Mingo-Santos, Susana
    Mirelis, Jesus G.
    Dominguez, Fernando
    Gonzalez-Lopez, Esther
    Perlini, Stefano
    Pontone, Gianluca
    Gillmore, Julian
    Hawkins, Philip N.
    Garcia-Pavia, Pablo
    Emdin, Michele
    Fontana, Marianna
    [J]. JACC-CARDIOVASCULAR IMAGING, 2020, 13 (04) : 909 - 920
  • [6] Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
    Castano, Adam
    Narotsky, David L.
    Hamid, Nadira
    Khalique, Omar K.
    Morgenstern, Rachelle
    DeLuca, Albert
    Rubin, Jonah
    Chiuzan, Codruta
    Nazif, Tamim
    Vahl, Torsten
    George, Isaac
    Kodali, Susheel
    Leon, Martin B.
    Hahn, Rebecca
    Bokhari, Sabahat
    Maurer, Mathew S.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (38) : 2879 - 2887
  • [7] Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis
    Chacko, Liza
    Martone, Raffaele
    Bandera, Francesco
    Lane, Thirusha
    Martinez-Naharro, Ana
    Boldrini, Michele
    Rezk, Tamer
    Whelan, Carol
    Quarta, Cristina
    Rowczenio, Dorota
    Gilbertson, Janet A.
    Wongwarawipat, Tanakal
    Lachmann, Helen
    Wechalekar, Ashutosh
    Sachchithanantham, Sajitha
    Mahmood, Shameem
    Marcucci, Rossella
    Knight, Daniel
    Hutt, David
    Moon, James
    Petrie, Aviva
    Cappelli, Francesco
    Guazzi, Marco
    Hawkins, Philip N.
    Gillmore, Julian D.
    Fontana, Marianna
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (14) : 1439 - +
  • [8] Clemmensen Tor Skibsted, 2017, Eur J Heart Fail, V19, P1457, DOI 10.1002/ejhf.899
  • [9] Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis
    Cohen, Oliver C.
    Ismael, Andreia
    Pawarova, Babita
    Manwani, Richa
    Ravichandran, Sriram
    Law, Steven
    Foard, Darren
    Petrie, Aviva
    Ward, Sevda
    Douglas, Brooke
    Martinez-Naharro, Ana
    Chacko, Liza
    Quarta, Candida Cristina
    Mahmood, Shameem
    Sachchithanantham, Sajitha
    Lachmann, Helen J.
    Hawkins, Philip N.
    Gillmore, Julian D.
    Fontana, Marianna
    Falk, Rodney H.
    Whelan, Carol J.
    Wechalekar, Ashutosh D.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (04) : 333 - 341
  • [10] Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis
    Dispenzieri, A
    Gertz, MA
    Kyle, RA
    Lacy, MQ
    Burritt, MF
    Therneau, TM
    Greipp, PR
    Witzig, TE
    Lust, JA
    Rajkumar, SV
    Fonseca, R
    Zeldenrust, SR
    McGregor, CGA
    Jaffe, AS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3751 - 3757